MEDCAP Aktie

 

Abilia, a subsidiary to MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire LivAssured B.V. in the Netherlands. The transaction is expected to close shortly. LivAssured's product Nightwatch is a medical device that detects epileptic seizures, and has been developed for more than 10 years with significant commercial progress achieved in Europe in recent years. The company currently has a turnover of approx. 4 MEUR and 15 employees, and an ambitious growth plan. The acquisition complements the offering of Abilia and the Business Area Assistive Tech....

MedCap's wholly owned subsidiary, Unimedic Pharma AB, has today completed the previously announced acquisition of 100% of the shares in XGX Pharma ApS (“XGX”) in Denmark. The acquisition was announced on June 25, 2025, and has now received the necessary regulatory approval (Foreign Direct Investment) in Denmark....

MedCap's wholly owned subsidiary, Unimedic Pharma AB, has signed an agreement to acquire XGX Pharma ApS (“XGX”) in Denmark. XGX is a fast-growing specialty pharma company with a pipeline of new products. Currently, XGX's has 7 products on the market, primarily in the Nordics. The pipeline consists of 20 niche products in either late-stage development or registration phase. Expected product launches for this pipeline will be during the coming years. XGX's net sales during the last 12 months amounted to 51m DKK, a growth of 91% compared to the same period previous year. The EBITDA margin...